{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for m root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
NCT04553692: Phase 1 Interventional Active, not recruiting Solid Tumor
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04669015: Phase 3 Interventional Unknown status Covid19
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:miromavimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:MAVEROPEPIMUT-S COMPONENT SURA2.M [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efdoralprin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04631016: Phase 2 Interventional Completed Chronic Obstructive Pulmonary Disease (COPD)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03976401: Phase 2 Interventional Completed NASH - Nonalcoholic Steatohepatitis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efbalropendekin alfa [INN]
Source URL:
Class:
PROTEIN